Showing results (81-90 of 108) with videos related to
Sort By:
Pageof 11
Nature Communications|May 30, 2023
Antibody blockade of Jagged1 attenuates choroidal neovascularizationTorleif Tollefsrud Gjølberg, Jonas Aakre Wik, Hanna Johannessen, et al.Mabs|March 16, 2022
Progress and challenges for the machine learning-based design of fit-for-purpose monoclonal antibodiesRahmad Akbar, Habib Bashour, Puneet Rawat, et al.Proceedings of the National Academy of Sciences of the United States of America|September 14, 2018
TRIM21 mediates antibody inhibition of adenovirus-based gene delivery and vaccinationMaria Bottermann, Stian Foss, Laurens M van Tienen, et al.Nature Communications|February 14, 2018
A human endothelial cell-based recycling assay for screening of FcRn targeted moleculesAlgirdas Grevys, Jeannette Nilsen, Kine M K Sand, et al.Cell Host & Microbe|March 31, 2019
Complement C4 Prevents Viral Infection through Capsid InactivationMaria Bottermann, Stian Foss, Sarah L Caddy, et al.Protein Science : a Publication of the Protein Society|October 28, 2023
Phage display assisted discovery of a pH-dependent anti-α-cobratoxin antibody from a natural variable domain libraryTulika Tulika, Rasmus W Pedersen, Charlotte Rimbault, et al.Frontiers in Immunology|June 22, 2023
Disruption of the sialic acid/Siglec-9 axis improves antibody-mediated neutrophil cytotoxicity towards tumor cellsMarta Lustig, Chilam Chan, J H Marco Jansen, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 25, 2013
Chimeric anti-CD14 IGG2/4 Hybrid antibodies for therapeutic intervention in pig and human models of inflammationCorinna Lau, Kristin S Gunnarsen, Lene S Høydahl, et al.PNAS Nexus|March 5, 2025
Engineering of anticancer human immunoglobulin A equipped with albumin for enhanced plasma half-lifeSimone Mester, Chilam Chan, Marta Lustig, et al.Scientific Reports|April 28, 2015
Developing the IVIG biomimetic, hexa-Fc, for drug and vaccine applicationsDaniel M Czajkowsky, Jan Terje Andersen, Anja Fuchs, et al.Pageof 11